×
About 1,570 results

ALLMedicine™ Takayasu Arteritis Center

Research & Reviews  591 results

Risk factors and surgical prognosis in patients with aortic valve involvement caused by...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077813
Arthritis Research & Therapy; Shi X, Du J et. al.

May 8th, 2022 - Aortic valve involvement is not uncommon in patients with Takayasu arteritis (TAK) and leading to poor prognosis. The aim of our study was to explore the risk factors of aortic valve involvement and to evaluate the prognosis in TAK patients with a...

Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in...
https://doi.org/10.1016/j.semarthrit.2022.152018
Seminars in Arthritis and Rheumatism; Wang J, Dai X et. al.

May 7th, 2022 - To investigate the efficacy and safety of leflunomide (LEF) versus tofacitinib (TOF) in Takayasu arteritis (TAK) patients. Sixty-seven active patients were recruited from an ongoing observational TAK cohort, including 35 patients treated with gluc...

A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
https://clinicaltrials.gov/ct2/show/NCT04882072

Apr 28th, 2022 - The purpose of this study is to evaluate the efficacy of ustekinumab compared to placebo, in combination with oral glucocorticoid (GC) taper regimen, in participants with relapsing Takayasu Arteritis (TAK).

A single-center cohort of mid-aortic syndrome among adults in China: etiology, presenta...
https://doi.org/10.1016/j.amjms.2022.04.004
The American Journal of the Medical Sciences; Meng X, Xue J et. al.

Apr 16th, 2022 - Mid-aortic syndrome (MAS), characterized by segmental stricture of the distal thoracic and abdominal aorta, is a heterogeneous clinical syndrome with multiple etiologies. We retrospectively analyzed 143 consecutive patients (99 females and 44 male...

see more →

Guidelines  4 results

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/acr.24632
Arthritis Care & Research; Maz M, Chung SA et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Clinical questions regarding diagnostic testing, treatment, and ma...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/art.41774
Arthritis & Rheumatology (Hoboken, N.J.); Maz M, Chung SA et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Clinical questions regarding diagnostic testing, treatment, and ma...

2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
https://doi.org/10.1136/annrheumdis-2019-215672
Annals of the Rheumatic Diseases; Hellmich B, Agueda A et. al.

Jul 5th, 2019 - Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical trials and cohort analyses have been published, which have th...

Consensus statement on surgical pathology of the aorta from the Society for Cardiovascu...
https://doi.org/10.1016/j.carpath.2015.05.001
Cardiovascular Pathology : the Official Journal of the So... Stone JR, Bruneval P et. al.

Jun 9th, 2015 - Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with excessive inflammatory responses, such as inflammatory atherosclerotic aneurysms. The nomenclature and histologic features of thes...

see more →

Clinicaltrials.gov  6 results

A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
https://clinicaltrials.gov/ct2/show/NCT04882072

Apr 28th, 2022 - The purpose of this study is to evaluate the efficacy of ustekinumab compared to placebo, in combination with oral glucocorticoid (GC) taper regimen, in participants with relapsing Takayasu Arteritis (TAK).

A Study to Evaluate the Efficacy and Safety of Upadacitinib in Subjects With Takayasu Arteritis (TAK)
https://clinicaltrials.gov/ct2/show/NCT04161898

Nov 8th, 2021 - The main objective of this study is to evaluate the efficacy of upadacitinib in combination with a corticosteroid taper regimen compared to placebo in combination with a corticosteroid taper regimen.

The Registry Study of Takayasu Arteritis in East China
https://clinicaltrials.gov/ct2/show/NCT03893136

Aug 10th, 2021 - Overview of Takayasu's arteritis. Takayasu arteritis (TA) is a chronic inflammatory blood vessel that seriously endangers human health, which affects a large variety of blood vessels, characterized by vascular stenosis and occlusion. The clinical ...

PET Imaging of Giant Cell and Takayasu Arteritis
https://clinicaltrials.gov/ct2/show/NCT04071691

Jun 23rd, 2021 - Up-regulation of SST2 in activated macrophages represents a novel imaging target for measuring vascular inflammation, which has been previously examined in atherosclerosis using 68Ga-DOTATATE. To test the hypothesis that SST2 PET imaging can accur...

Clinical Characteristics of Allergy, Autoimmune and Rheumatic Diseases: A Ten Year Retrospective Study
https://clinicaltrials.gov/ct2/show/NCT01611636

Jun 23rd, 2020 - The incidence and prevalence of the allergic, autoimmune and rheumatic diseases are different all over the world. The relative impact of gene and environment on diseases can be revealed by studies from different populations. National Health Insura...

see more →

News  26 results

New ACR Guidelines Give Advice on Six Forms of Vasculitis
https://www.medscape.com/viewarticle/954873

Jul 15th, 2021 - Three new guidelines from the American College of Rheumatology, in partnership with the Vasculitis Foundation, offer evidence-based recommendations for managing and treating six different forms of systemic vasculitis. Dr Sharon Chung "It's not unu...

Three new ACR guidelines recommend treatment for six forms of vasculitis
https://www.mdedge.com/rheumatology/article/242933/lupus-connective-tissue-diseases/three-new-acr-guidelines-recommend
Steve Cimino

Jul 14th, 2021 - Three new guidelines from the American College of Rheumatology, in partnership with the Vasculitis Foundation, offer evidence-based recommendations for managing and treating six different forms of systemic vasculitis. Dr.

Upadacitinib Clears Atopic Dermatitis Faster Than Dupilumab
https://www.medscape.com/viewarticle/949813

Apr 23rd, 2021 - An oral Janus kinase 1 (JAK1) inhibitor, upadacitinib (Rinvoq), relieves the symptoms of atopic dermatitis (AD) better than dupilumab (Dupixent), researchers say. "The differences between the two drugs were more pronounced when we looked at higher...

In vasculitis, the skin tells the story
https://www.mdedge.com/infectiousdisease/article/207159/autoimmune-diseases/vasculitis-skin-tells-story?channel=39313
Kari Oakes

Aug 27th, 2019 - MILAN – Skin manifestations of the vasculitides can point the way to an accurate diagnosis and provide clues about disease severity, Robert Micheletti, MD, said at the World Congress of Dermatology. Dr.

In vasculitis, the skin tells the story
https://www.mdedge.com/dermatology/article/207159/autoimmune-diseases/vasculitis-skin-tells-story
Kari Oakes

Aug 27th, 2019 - MILAN – Skin manifestations of the vasculitides can point the way to an accurate diagnosis and provide clues about disease severity, Robert Micheletti, MD, said at the World Congress of Dermatology. Dr.

see more →

Patient Education  1 results see all →